134 related articles for article (PubMed ID: 23298438)
1. Dosimetric parameter predicting the deterioration of hepatic function after helical tomotherapy in patients with unresectable locally advanced hepatocellular carcinoma.
Son SH; Kay CS; Song JH; Lee SW; Choi BO; Kang YN; Jang JW; Yoon SK; Jang HS
Radiat Oncol; 2013 Jan; 8():11. PubMed ID: 23298438
[TBL] [Abstract][Full Text] [Related]
2. Reducing the probability of radiation-induced hepatic toxicity by changing the treatment modality from helical tomotherapy to fixed-beam intensity-modulated radiotherapy.
Song JH; Son SH; Kay CS; Jang HS
Oncotarget; 2015 Oct; 6(32):33952-60. PubMed ID: 26376679
[TBL] [Abstract][Full Text] [Related]
3. Significance of an increase in the Child-Pugh score after radiotherapy in patients with unresectable hepatocellular carcinoma.
Son SH; Jang HS; Jo IY; Choi BO; Jang JW; Yoon SK; Kay CS
Radiat Oncol; 2014 Apr; 9():101. PubMed ID: 24779518
[TBL] [Abstract][Full Text] [Related]
4. Identification of Biologically Effective Dose-Volumetric Parameters That Predict Radiation-Induced Hepatic Toxicity in Patients Treated With Helical Tomotherapy for Unresectable Locally Advanced Hepatocellular Carcinoma.
Song JH; Son SH; Kay CS; Jang HS
Medicine (Baltimore); 2015 Oct; 94(43):e1904. PubMed ID: 26512611
[TBL] [Abstract][Full Text] [Related]
5. Determination of the α/β ratio for the normal liver on the basis of radiation-induced hepatic toxicities in patients with hepatocellular carcinoma.
Son SH; Jang HS; Lee H; Choi BO; Kang YN; Jang JW; Yoon SK; Kay CS
Radiat Oncol; 2013 Mar; 8():61. PubMed ID: 23497395
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: dose-volumetric parameters predicting the hepatic complication.
Son SH; Choi BO; Ryu MR; Kang YN; Jang JS; Bae SH; Yoon SK; Choi IB; Kang KM; Jang HS
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1073-80. PubMed ID: 20207492
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric Analysis and Normal-Tissue Complication Probability Modeling of Child-Pugh Score and Albumin-Bilirubin Grade Increase After Hepatic Irradiation.
Pursley J; El Naqa I; Sanford NN; Noe B; Wo JY; Eyler CE; Hwang M; Brock KK; Yeap BY; Wolfgang JA; Hong TS; Grassberger C
Int J Radiat Oncol Biol Phys; 2020 Aug; 107(5):986-995. PubMed ID: 32353390
[TBL] [Abstract][Full Text] [Related]
8. A prospective cohort study of hepatic toxicity after stereotactic body radiation therapy for hepatocellular carcinoma.
Su TS; Luo R; Liang P; Cheng T; Zhou Y; Huang Y
Radiother Oncol; 2018 Oct; 129(1):136-142. PubMed ID: 29548558
[TBL] [Abstract][Full Text] [Related]
9. Identifying the optimal criteria of radiotherapeutic parameters for patients with unresectable locally advanced hepatocellular carcinoma.
Son SH; Jang HS; Sung SY; Kang HJ; Lee S; Kay CS
Oncotarget; 2015 Dec; 6(39):42372-9. PubMed ID: 26510905
[TBL] [Abstract][Full Text] [Related]
10. Non-classic radiation-induced liver disease after intensity-modulated radiotherapy for Child-Pugh grade B patients with locally advanced hepatocellular carcinoma.
Li JX; Zhang RJ; Qiu MQ; Yan LY; He ML; Long MY; Zhong JH; Lu HY; Zhou HM; Xiang BD; Liang SX
Radiat Oncol; 2023 Mar; 18(1):48. PubMed ID: 36890592
[TBL] [Abstract][Full Text] [Related]
11. Volumetric intensity-modulated Arc (RapidArc) therapy for primary hepatocellular carcinoma: comparison with intensity-modulated radiotherapy and 3-D conformal radiotherapy.
Kuo YC; Chiu YM; Shih WP; Yu HW; Chen CW; Wong PF; Lin WC; Hwang JJ
Radiat Oncol; 2011 Jun; 6():76. PubMed ID: 21693003
[TBL] [Abstract][Full Text] [Related]
12. Feasibility and efficacy of helical tomotherapy in cirrhotic patients with unresectable hepatocellular carcinoma.
Huang CM; Huang MY; Tang JY; Chen SC; Wang LY; Lin ZY; Huang CJ
World J Surg Oncol; 2015 Jun; 13():201. PubMed ID: 26072055
[TBL] [Abstract][Full Text] [Related]
13. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy.
Kim TH; Kim DY; Park JW; Kim SH; Choi JI; Kim HB; Lee WJ; Park SJ; Hong EK; Kim CM
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):225-31. PubMed ID: 17056199
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a nomogram for radiation-induced hepatic toxicity after intensity modulated radiotherapy for hepatocellular carcinoma: a retrospective study.
Wu Q; Wang Y; Wei Y; Yang Z; Chen K; Li J; Li L; Su T; Liang S
Jpn J Clin Oncol; 2024 Jun; 54(6):699-707. PubMed ID: 38376811
[TBL] [Abstract][Full Text] [Related]
15. Predictors of Liver Toxicity Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.
Velec M; Haddad CR; Craig T; Wang L; Lindsay P; Brierley J; Brade A; Ringash J; Wong R; Kim J; Dawson LA
Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):939-946. PubMed ID: 28333016
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease.
Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Tsai SY; Cheng SH; Jian JJ; Huang AT
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):229-34. PubMed ID: 12694843
[TBL] [Abstract][Full Text] [Related]
17. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication.
Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Cheng SH; Tsai SY; Jian JJ; Lin YM; Cheng TI; Horng CF; Huang AT
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):156-62. PubMed ID: 12182986
[TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Accelerated Hypofractionation and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients With Varying Degrees of Hepatic Impairment.
Nabavizadeh N; Waller JG; Fain R; Chen Y; Degnin CR; Elliott DA; Mullins BT; Patel IA; Dyer BA; Fakhoury K; Naugler WE; Farsad K; Tanyi JA; Fuss M; Thomas CR; Hung AY
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):577-585. PubMed ID: 29413273
[TBL] [Abstract][Full Text] [Related]
19. Phase I dose escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma.
Kim JW; Seong J; Lee IJ; Woo JY; Han KH
Oncotarget; 2016 Jun; 7(26):40756-40766. PubMed ID: 27213593
[TBL] [Abstract][Full Text] [Related]
20. Accelerated treatment using intensity-modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma.
McIntosh A; Hagspiel KD; Al-Osaimi AM; Northup P; Caldwell S; Berg C; Angle JF; Argo C; Weiss G; Rich TA
Cancer; 2009 Nov; 115(21):5117-25. PubMed ID: 19642177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
